{"id":10165,"date":"2020-12-02T22:09:49","date_gmt":"2020-12-02T13:09:49","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=10165"},"modified":"2025-07-28T11:30:29","modified_gmt":"2025-07-28T02:30:29","slug":"diseaselist_5","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/hps\/patient_specific_ips\/diseaselist_5","title":{"rendered":"Circulatory system diseases, Hematologic diseases"},"content":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address.
\n\uff0a In relation to the information that are not described below, please e-mail to the following address.<\/p>\n

Contact us :\u00a0cellips.brc\"\"riken.jp<\/a><\/p>\n

Blue letter cells are available. You obtain the information by clicking the blue letter.
\n*iPS cells created using the Sendai virus vector are now available<\/a><\/p>\n

*Terms:
\nIn relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary.
\nIn relation to all iPS cell lines, commercial use is prohibited.
\nIn relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize.<\/p>\n

Update : 2020.11.27<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Name of diseases<\/th>\nPatient No.<\/th>\n*Terms<\/th>\nApproval Form<\/th>\nHPS<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\nReferences<\/th>\n<\/tr>\n
Circulatory system diseases<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. Dilated cardiomyopathy (DCM)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Dilated cardiomyopathy (DCM)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0404<\/td>\nHPS0405<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS0406<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Familial dilated cardiomyopathy<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1799<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS1800<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\n<\/td>\n<\/td>\nHPS1801<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\n<\/td>\n<\/td>\nHPS1803<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\n<\/td>\n<\/td>\nHPS1804<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\n<\/td>\n<\/td>\nHPS3525<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\n<\/td>\n<\/td>\nHPS3526<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8<\/td>\n<\/td>\n<\/td>\nHPS3527<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9<\/td>\n<\/td>\n<\/td>\nHPS3662<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
10<\/td>\n<\/td>\n<\/td>\nHPS3663<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Dilated cardiomyopathy (DCM)<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2407<\/a><\/td>\nHPS2408<\/a><\/td>\nHPS2409<\/a><\/td>\nHPS2410<\/td>\nHPS2411<\/td>\nHPS2412<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3006<\/a><\/td>\nHPS3007<\/a><\/td>\nHPS3008<\/a><\/td>\nHPS3009 <\/td>\nHPS3010 <\/td>\nHPS3011 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\n<\/td>\n<\/td>\nHPS3971<\/td>\nHPS3972<\/td>\nHPS3973<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>4<\/td>\n<\/td>\n<\/td>\nHPS3974<\/td>\nHPS3975<\/td>\nHPS3976<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>5<\/td>\n<\/td>\n<\/td>\nHPS4276<\/td>\nHPS4277<\/td>\nHPS4278<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. Hypertrophic cardiomyopathy (HCM)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Hypertrophic cardiomyopathy (HCM)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0402<\/td>\nHPS0403<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS0957*<\/td>\nHPS0958*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Hypertrophic cardiomyopathy, midventricular obstruction (HOCM)<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2944<\/a><\/td>\nHPS2945<\/a><\/td>\nHPS2946<\/a><\/td>\nHPS2947<\/td>\nHPS2948<\/td>\nHPS2949<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Danon disease, dilated phase of hypertrophic cardiomyopathy<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1805<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS3664<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Familial hypertrophic cardiomyopathy, dilated phase<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1811<\/td>\nHPS1812<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Familial hypertrophic cardiomyopathy (HCM)<\/td>\n<\/a>1<\/td>\n<\/td>\n<\/td>\nHPS0959<\/td>\nHPS0960<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS1802<\/td>\nHPS3528<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\n<\/td>\n<\/td>\nHPS1844<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\n<\/td>\n<\/td>\nHPS3661<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Tricuspid atresia<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>Tricuspid atresia<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3248<\/td>\nHPS3249<\/td>\nHPS3250<\/td>\nHPS3251<\/td>\nHPS3252<\/td>\nHPS3253<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Hematologic diseases<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. Aplastic anemi<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>Aplastic anemia, idiopathic aplastic anemia<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2690<\/a><\/td>\nHPS2691<\/a><\/td>\nHPS2692<\/a><\/td>\nHPS2693<\/td>\nHPS2694<\/td>\nHPS2695<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. Autoimmune hemolytic anemia (AHA),<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>Autoimmune hemolytic anemia (AHA), idiopathic warm (AHA)<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1994<\/td>\nHPS1995<\/td>\nHPS1996<\/td>\nHPS1997<\/td>\nHPS1998<\/td>\nHPS1999<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Paroxysmal nocturnal hemoglobinuria (PNH)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1403<\/a><\/td>\nHPS1404<\/td>\nHPS1405<\/td>\nHPS1406<\/td>\nHPS1407<\/td>\nHPS1408<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2198<\/a><\/td>\nHPS2199<\/td>\nHPS2200<\/td>\nHPS2201<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2419 \"NEW\"<\/td>\nHPS2420 \"NEW\"<\/td>\nHPS2421 \"NEW\"<\/td>\nHPS2422 \"NEW\"<\/td>\nHPS2423 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3149<\/a><\/td>\nHPS3150<\/td>\nHPS3151<\/td>\nHPS3152<\/td>\nHPS3153<\/td>\nHPS3154<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4. Idiopathic thrombocytopenic purpura<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>Idiopathic thrombocytopenic purpura<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1318<\/a><\/td>\nHPS1319<\/a><\/td>\nHPS1320<\/a><\/td>\nHPS1321<\/td>\nHPS1322<\/td>\nHPS1323<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2307<\/a><\/td>\nHPS2308<\/a><\/td>\nHPS2309<\/a><\/td>\nHPS2310<\/td>\nHPS2311<\/td>\nHPS2312<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5. Thrombotic thrombocytopenic purpura (TTP)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Thrombotic thrombocytopenic purpura (TTP)<\/a><\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1966<\/td>\nHPS1967<\/td>\nHPS1968<\/td>\nHPS1969<\/td>\nHPS1970<\/td>\nHPS1971<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6. Primary immunodeficiency syndrome (PIDS)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Adenosine deaminase deficiency (ADA)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0265<\/a><\/td>\nHPS0266<\/a><\/td>\nHPS0267<\/a><\/td>\nHPS0268<\/td>\nHPS0269<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Chronic granulomatous disease (CGD), p47phox-deficiency<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0334*<\/a><\/td>\nHPS0335*<\/a><\/td>\nHPS0336*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0337*<\/a><\/td>\nHPS0338*<\/a><\/td>\nHPS0339*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\nUnnecessary<\/td>\nHPS3954*<\/td>\nHPS3955*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary immunodeficiency syndrome<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2618<\/td>\nHPS2619<\/td>\nHPS2620<\/td>\nHPS2621<\/td>\nHPS2622<\/td>\nHPS2623<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary immunodeficiency syndrome, common variable immunodeficiency<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1361<\/td>\nHPS1362<\/td>\nHPS1363<\/td>\nHPS1364<\/td>\nHPS1365<\/td>\nHPS1366<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary immunodeficiency syndrome, X-linked agammaglobulinemia<\/td>\n<\/a><\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3314<\/td>\nHPS3315<\/td>\nHPS3316<\/td>\nHPS3317<\/td>\nHPS3318<\/td>\nHPS3319<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Reticular dysgenesis<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS3857<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3500<\/td>\nHPS3501<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3518<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3519<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/a><\/td>\n<\/td>\n<\/td>\nHPS3858<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3502<\/td>\nHPS3503<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3520<\/td>\nHPS3521<\/td>\nHPS3522<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Ch\u00e9diak-Higashi syndrome<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0515<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/a><\/td>\n<\/td>\n<\/td>\nHPS0516<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Wiskott-Aldrich syndrome (WAS)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1837*<\/td>\nHPS1838*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/a><\/td>\n<\/td>\n<\/td>\nHPS1839*<\/td>\nHPS1840*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7. Diamond-Blackfan anemia<\/span><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Diamond-Blackfan anemia<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1126<\/a><\/td>\nHPS1127<\/a><\/td>\nHPS1128<\/a><\/td>\nHPS1129<\/td>\nHPS1130<\/td>\nHPS1131<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/td>\nUnnecessary<\/td>\nHPS1132<\/a><\/td>\nHPS1133<\/a><\/td>\nHPS1134<\/a><\/td>\nHPS1135<\/td>\nHPS1136<\/td>\nHPS1137<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS3504<\/td>\nHPS3505<\/td>\nHPS3506<\/td>\nHPS3507<\/td>\nHPS3508<\/td>\nHPS3509<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3510<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3511<\/td>\nHPS3512<\/td>\nHPS3513<\/td>\nHPS3514<\/td>\nHPS3515<\/td>\nHPS3516<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\n<\/td>\n<\/td>\nHPS3517<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8. Fanconi anemia<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Fanconi anemia<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS3492<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS0512<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS3493<\/td>\nHPS3494<\/td>\nHPS3495<\/td>\nHPS3497<\/td>\nHPS3498<\/td>\nHPS3499<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address. \uff0a In relation to the information that are not described below, please e-mail to the following address. Contact us :\u00a0cellips.brcriken.jp Blue letter cells are available. You obtain the information by clicking the blue letter. *iPS cells created using the Sendai virus vector are now available *Terms: In relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary. In relation to all iPS cell lines, commercial use is prohibited. In relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize. Update : 2020.11.27 Name of diseases Patient No. *Terms Approval Form HPS References Circulatory system diseases 1. Dilated cardiomyopathy (DCM) Dilated cardiomyopathy (DCM) 1 HPS0404 HPS0405 2 HPS0406 Familial dilated cardiomyopathy 1 HPS1799 2 HPS1800 3 HPS1801 4 HPS1803 5 HPS1804 6 HPS3525 7 HPS3526 8 HPS3527 9 HPS3662 10 HPS3663 Dilated cardiomyopathy (DCM) 1 \u25ce Unnecessary HPS2407 HPS2408 HPS2409 HPS2410 HPS2411 HPS2412 2 […]<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":10124,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-10165","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=10165"}],"version-history":[{"count":5,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10165\/revisions"}],"predecessor-version":[{"id":10805,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10165\/revisions\/10805"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10124"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=10165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}